Hibbard, JU, Shroff, SG, Cunningham, FG. Cardiovascular alterations in normal and preeclamptic pregnancies. In Taylor, RN, Roberts, JM, Cunningham, FG (eds): Chesley’s Hypertensive Disorders in Pregnancy, 4th edn. Amsterdam, Academic Press, 2014.Google Scholar

Clapp, JF, Capeless, E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 1997;80(11):1469–73.CrossRefGoogle ScholarPubMed

Duvekot, JJ, Cheriex, EC, Pieters, FA, et al: Early pregnancy changes in hemodynamics and volume homeostatis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol 1993;169:1382.Google Scholar

MacGillivray, I, Rose, GA, Rowe, B. Blood pressure survey in pregnancy. Clin Sci. 1969;37(2):395–407.Google Scholar

World Health Organization International Collaborative Study of Hypertensive Disorders in Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol. 1988;158: 80–3.Google Scholar

Sibai, B, Dekker, G, Kupferminc, M. Pre-eclampsia. Lancet 2005;365:785–99.CrossRefGoogle ScholarPubMed

Cedergren, M. Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int. J. Gynaecol Obstet 2006; 93:269–74.Google Scholar

Redman, CW, Sargent, IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–4.Google Scholar

Khong, TY, De Wolf, F, Robertson, WB, Brosens, I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049–59.Google Scholar

Widmer, M, Villar, J, Benigni, A, Conde-Agudelo, A, Karumanchi, SA, Lindheimer, M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol. 2007 Jan;109(1):168–80.CrossRefGoogle ScholarPubMed

Meher, S, Duley, L. Prevention of Pre-eclampsia Cochrane Review Authors. Interventions for preventing preeclampsia and its consequences: generic protocol. Cochrane Database of Systematic Reviews 2005; 2. [doi: 10.1002/ 14651858.CD005301]CrossRefGoogle Scholar

Redman, CW, Sacks, GP, Sargent, IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180: 499–506.CrossRefGoogle ScholarPubMed

Everett, TR, Mahendru, AA, McEniery, CM, Wilkinson, IB, Lees, CC. Raised uterine artery impedance is associated with increased maternal arterial stiffness in the late second trimester. Placenta. 2012;33(7):572–7. doi: 10.1016/j.placenta.2012.04.001. Epub 2012 Apr 24.Google Scholar

Ghidini, A, Locatelli, A. Monitoring of fetal well-being: role of uterine artery Doppler. Semin Perinatol. 2008;32(4):258–62. doi: 10.1053/j.semperi.2008.04.019.CrossRefGoogle ScholarPubMed

Napolitano, R, Thilaganathan, B. Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies. Am J Obstet Gynecol. 2012;206(6):e8–9; author reply e9. doi: 10.1016/j.ajog.2012.02.030. Epub 2012 Mar 6.CrossRefGoogle ScholarPubMed

Groom, KM, North, RA, Stone, PR, et al. SCOPE Consortium. Patterns of change in uterine artery Doppler studies between 20 and 24 weeks of gestation and pregnancy outcomes. Obstet Gynecol. 2009;113(2, Pt 1):332–8. doi: 10.1097/AOG.0b013e318195b223.Google Scholar

Myatt, L, Clifton, RG, Roberts, JM, et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol. 2012;119(6):1234–42. doi: 10.1097/AOG.0b013e3182571669.Google Scholar

George, EM, Granger, JP. Mechanisms and potential therapies for preeclampsia. Curr Hypertens Rep 2011;13:269–75.Google Scholar

Goulopoulou, S, Davidge, ST. Molecular mechanisms of maternal vascular dysfunction in preeclampsia. Trends Mol Med 2015;21:88–97.CrossRefGoogle ScholarPubMed

Moncada, S, Higgs, A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002–12.Google Scholar

Jeremy, JY, Rowe, D, Emsley, AM, Newby, AC. Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc Res 1999; 43:580–94.Google Scholar

Gaboury, JP, Niu, XF, Kubes, P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 1996; 93:318–26.Google Scholar

Krause, BJ, Hanson, MA, Casanello, P. Role of nitric oxide in placental vascular development and function. Placenta. 2011; 32(11): 797–805. doi: 10.1016/j.placenta.2011.06.025.Google Scholar

Kulandavelu, S, Whiteley, KJ, Bainbridge, SA, et al. Endothelial NO synthase augments fetoplacental blood flow, placental vascularization, and fetal growth in mice. Hypertension. 2013;61(1):259–66. doi: 10.1161/HYPERTENSIONAHA.112.201996. Epub 2012 Nov 12.Google Scholar

Learmont, JG, Poston, L. Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries. Am J Obstet Gynecol 1996; 174: 1056–60.Google Scholar

Hubel, CA, Kagan, VE, Kisin, ER, McLaughlin, MK, Roberts, JM. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: implications for oxidative stress. Free Radic Biol Med 1997;23:597–609.Google Scholar

Lowe, DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 2000;4(4):441–58.CrossRefGoogle ScholarPubMed

Davidge, ST, Stranko, CP, Roberts, JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 1996;174(3):1008–13.Google Scholar

Seligman, SP, Buyon, JP, Clancy, RM, Young, BK, Abramson, SB. The role of nitric oxide in the pathogenesis of preeclampsia. American Journal of Obstetrics and Gynecology 1994;171:944–8.Google Scholar

Delacretaz, E, DeQuay, N, Waeber, B, et al. Differential nitric oxide synthase activity in human platelets during normal pregnancy and preeclampsia. Clin Sci 1995;88:607–10.Google Scholar

Neri, I, Piccinini, F, Marietta, M, Facchinetti, F, Volpe, A. Platelet responsiveness to L-arginine in hypertensive disorders of pregnancy. Hypertension in Pregnancy 2000;19(3):323–30.Google Scholar

Fickling, SA, Williams, D, Vallance, P, Nussey, SS, Whitley, GStJ. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet 1993;342:242–3.Google Scholar

Noris, M, Todeschini, M, Cassis, P, et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004;43(3):614–22.Google Scholar

Morris, NH, Sooranna, SR, Learmont, JG, et al. Nitric oxide synthase activities in placental tissue from normotensive, preeclamptic, and growth retarded fetuses. Br J Obstet Gynaecol 1995;102:711–4.Google Scholar

Wu, G, Meininger, CJ. Arginine nutrition and cardiovascular function. J Nutr 2000;130(11):2626–9Google Scholar

Vadillo-Ortega, F, Perichart-Perera, O, Espino, S, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: Randomised controlled trial. BMJ 2011;342:d2901CrossRefGoogle ScholarPubMed

Rumbold, A, Duley, L, Crowther, CA, Haslam, RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 2008;1. CD004227. doi: 10.1002/14651858.CD004227.pub3.Google Scholar

Meher, S, Duley, L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;18(2):CD006490.Google Scholar

Powers, R, Weissgerber, TL, McGonigal, S, et al. [7-OR]: L-citrulline administration increases the arginine/ ADMA ratio, decreases blood pressure and improves vascular function in obese pregnant women. Pregnancy Hypertens 2015;5(1):4Google Scholar

Molelekwa, V, Akhter, P, McKenna, P, et al. Eisenmenger’s syndrome in a 27 week pregnancy-management with bosentan and sildenafil. Ir Med J 2005;98(3):87–8Google Scholar

Lacassie, HJ, Germain, AM, Valdes, G, et al. Management of eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 2004;103(5, Pt 2):1118–20.Google Scholar

Wareing, M, Myers, JE, O’Hara, M, Baker, PN. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab 2005;90:2550–5.CrossRefGoogle ScholarPubMed

Maharaj, CH, O’Toole, D, Lynch, T, et al. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries. Reprod Biol Endocrinol 2009;7:34Google Scholar

Malinova, M. Sildenafil – for treatment of preeclampsia and intrauterine growth restriction. Akush Ginekol (Sofiia). 2014;53(1):40–3.Google Scholar

Von Dadelszen, P, Dwinnell, S, Magee, LA, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG 2011;118(5):624–8.Google Scholar

Trapani, A Jr, Gonçalves, LF, Pires, MM. Transdermal nitroglycerin in patients with severe preeclampsia with placental insufficiency: Effect on uterine, umbilical and fetal middle cerebral artery resistance indices. Ultrasound Obstet Gynecol 2011;38(4):389–94.Google Scholar

Cacciatore, B, Halmesmäki, E, Kaaja, R, et al. Effects of transdermal nitroglycerin on impedance to flow in the uterine, umbilical, and fetal middle cerebral arteries in pregnancies complicated by preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 1998;179(1):140–5.Google Scholar

Ramsay, B, De Belder, A, Campbell, S, et al. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur J Clin Invest 1994;24(1):76–8.Google Scholar

Grunewald, C, Kublickas, M, Carlström, K, et al. Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol 1995;86(4 Pt 1):600–4.CrossRefGoogle ScholarPubMed

Belkacemi, L, Bainbridge, SA, Dickinson, MA, Smith, GN. Glyceryl trinitrate inhibits hypoxia/reoxygenation-induced apoptosis in the syncytiotrophoblast of the human placenta: Therapeutic implications for preeclampsia. Am J Pathol 2007;170(3):909–20.Google Scholar

Lees, C, Langford, E, Brown, AS, de Belder, A, Pickles, A, Martin, JF. The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia. Obstetrics & Gynecology 1996;88:14–19.Google Scholar

Thaler, I, Amit, A, Kamil, D, Itskovitz-Eldor, J. The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension. Am J Hypertens 1999;12(4 Pt 1):341–7.Google Scholar

Cetin, A, Yurtcu, N, Guvenal, T, Imir, AG, Duran, B, Cetin, M. The effect of glyceryl trinitrate on hypertension in women with severe preeclampsia, HELLP syndrome, and eclampsia. Hypertens Pregnancy 2004; 23: 37–46.Google Scholar

Lees, C, Valensise, H, Black, R, et al. The efficacy and fetal–maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of preeclampsia and its complications: a randomized double-blind placebo-controlled trial. Ultrasound Obstet Gynecol 1998; 12:334–8.Google Scholar

Giles, W, O’Callaghan, S, Boura, A, Walters, W. Reduction in human fetal umbilical-placental vascular resistance by glyceryl trinitrate. Lancet 1992;340(8823):856.Google Scholar

Picciolo, C, Roncaglia, N, Neri, I, Pasta, F, Arreghini, A, Facchinetti, F. Nitric oxide in the prevention of pre-eclampsia. Prenat Neonatal Med 2000; 5: 212–15.Google Scholar

Chen, Z, Zhang, J, Stamler, JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A 2002; 99: 8306–11.Google Scholar

Miller, MR, Megson, IL. Recent developments in nitric oxide donor drugs. Br J Pharmacol 2007; 151: 305–21.CrossRefGoogle ScholarPubMed

Davis, G, Brown, M. Glyceryl trinitrate patches are unsuitable in hypertensive pregnancy. Aust N Z J Obstet Gynaecol 2001;41(4):474.Google Scholar

Duvekot, JJ, Cheriex, EC, Pieters, FA, Peeters, LH. Severely impaired fetal growth is preceded by maternal hemodynamic maladaptation in very early pregnancy. Acta Obstet Gynecol Scand 1995; 74: 693–7.Google Scholar

Duvekot, JJ, Cheriex, EC, Pieters, FA, Menheere, PP, Schouten, HJ, Peeters, LH. Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction. Obstet Gynecol 1995;85:361–7.CrossRefGoogle ScholarPubMed

Valensise, H, Vasapollo, B, Novelli, GP, et al. Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery. Ultrasound Obstet Gynecol 2008;31:55–64.Google Scholar

Valensise, H, Novelli, GP, Vasapollo, B, et al. Maternal cardiac systolic and diastolic function: relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study. Ultrasound Obstet Gynecol 2000; 15: 487–97.Google Scholar

Curran-Everett, D, Morris, KG Jr, Moore, LG. Regional circulatory contributions to increased systemic vascular conductance of pregnancy. Am J Physiol 1991;261:H1842–H1847.Google Scholar

Valensise, H, Vasapollo, B, Novelli, GP, Altomare, F, Arduini, D. Nitric oxide donors and fluid therapy increase fetal growth in gestational hypertension. 15th World Congress on Ultrasound in Obstetrics and Gynecology Poster abstracts.Google Scholar

Ariyaratnam, P, Loubani, M, Morice, AH. Hydrogen sulphide vasodilates human pulmonary arteries: A possible role in pulmonary hypertension? Microvasc Res 2013;90:135–7.Google Scholar

Zhao, W, Zhang, J, Lu, Y, Wang, R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001;20(21):6008–16.Google Scholar

Cindrova-Davies, T. Reduced cystathionine glyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: Hydrogen sulfide as a placental vasodilator. Am J Pathol 2013;182(4):1448.Google Scholar

Cai, W, Wang, M, Moore, PK, et al. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 2008;76(1):29–40.Google Scholar

Holwerda, KM. Hydrogen sulfide producing enzymes in pregnancy and preeclampsia. Placenta 2012;33(6):518–21.Google Scholar

Holwerda, KM, Burke, SD, Faas, MM, et al. Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. J Am Soc Nephrol 2014;25(4):717–25.CrossRefGoogle ScholarPubMed

Sharma, D, Singh, A, Trivedi, SS, Bhattacharjee, J. Role of endothelin and inflammatory cytokines in pre-eclampsia – a pilot North Indian study. Am J Reprod Immunol 2011;65(4):428–32.Google Scholar

Taylor, RN, Varma, M, Teng, NN, Roberts, JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990;71(6):1675–7.Google Scholar

Dekker, GA, Kraayenbrink, AA, Zeeman, GG, van Kamp, GJ. Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1991;40(3):215–20.Google Scholar

Clark, BA, Halvorson, L, Sachs, B, Epstein, FH. Plasma endothelin levels in preeclampsia: Elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol. 1992;166(3):962–8.Google Scholar

George, EM, Palei, AC, Granger, JP. Endothelin as a final common pathway in the pathophysiology of preeclampsia: Therapeutic implications. Curr Opin Nephrol Hypertens 2012;21(2):157–62.Google Scholar

Olson, GL, Saade, GR, Buhimschi, I, et al. The effect of an endothelin antagonist on blood pressure in a rat model of preeclampsia. Am J Obstet Gynecol 1999;181(3):638–41.Google Scholar

Alexander, BT, Rinewalt, AN, Cockrell, KL, et al. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 2001;37(2 Pt 2):485–9.Google Scholar